CASTLE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CASTLE BIOSCIENCES, INC. (CSTL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.38K shares, a 1887.65% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 170.00 shares, a 99.94% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 263.64K shares, a 68.66% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 0.00 shares 10-Q · filed 2026-07-30 | 0.00 shares derived: sum of 3 quarters · filed 2026-07-30 | 0.00 shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-06 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-06 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-03 | 0.00 shares 10-Q · filed 2025-11-03 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 0.00 shares 10-Q · filed 2025-08-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 3.38K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 3.38K shares derived: sum of 3 quarters · filed 2026-02-26 | 3.38K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 3.38K shares derived: sum of 2 quarters · filed 2026-02-26 | 3.38K shares derived: sum of 3 quarters · filed 2026-02-26 | 3.38K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 3.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 3.38K shares derived: sum of 2 quarters · filed 2024-11-04 | 3.38K shares 10-Q · filed 2024-11-04 | 3.38K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 0.00 shares 10-Q · filed 2024-08-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-02 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 79.00 shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 79.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 170.00 shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 79.00 shares derived: sum of 2 quarters · filed 2023-11-02 | 170.00 shares 10-Q · filed 2023-11-02 | 329.00 shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 79.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 170.00 shares 10-Q · filed 2023-08-02 | 329.00 shares derived: sum of 3 quarters · filed 2025-02-27 | 32.44K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 91.00 shares 10-Q · filed 2023-05-03 | 250.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 32.36K shares derived: sum of 3 quarters · filed 2025-02-27 | 236.13K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 159.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 32.27K shares derived: sum of 2 quarters · filed 2025-02-27 | 236.04K shares derived: sum of 3 quarters · filed 2025-02-27 | 263.64K shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 32.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 235.88K shares derived: sum of 2 quarters · filed 2022-11-02 | 263.49K shares 10-Q · filed 2022-11-02 | 863.22K shares derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | 203.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 231.38K shares 10-Q · filed 2022-08-08 | 831.11K shares derived: sum of 3 quarters · filed 2023-02-28 | 922.88K shares derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | 27.61K shares 10-Q · filed 2022-05-09 | 627.34K shares derived: sum of 2 quarters · filed 2023-02-28 | 719.10K shares derived: sum of 3 quarters · filed 2023-02-28 | 815.03K shares derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | 599.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 691.50K shares derived: sum of 2 quarters · filed 2023-02-28 | 787.43K shares derived: sum of 3 quarters · filed 2023-02-28 | 841.34K shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 91.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 187.69K shares derived: sum of 2 quarters · filed 2021-11-08 | 241.60K shares 10-Q · filed 2021-11-08 | 950.54K shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | 95.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 149.84K shares 10-Q · filed 2021-08-09 | 858.78K shares derived: sum of 3 quarters · filed 2022-02-28 | 1.15M shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | 53.91K shares 10-Q · filed 2021-05-10 | 762.85K shares derived: sum of 2 quarters · filed 2022-02-28 | 1.05M shares derived: sum of 3 quarters · filed 2022-02-28 | 1.17M shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | 708.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 995.95K shares derived: sum of 2 quarters · filed 2022-02-28 | 1.12M shares derived: sum of 3 quarters · filed 2022-02-28 | 1.29M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 287.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 407.92K shares derived: sum of 2 quarters · filed 2020-11-09 | 577.12K shares 10-Q · filed 2020-11-09 | 1.59M shares derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | 120.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 290.12K shares 10-Q · filed 2020-08-10 | 1.31M shares derived: sum of 3 quarters · filed 2021-03-11 | |
| 2020-03-31 | 169.20K shares 10-Q · filed 2020-05-11 | 1.18M shares derived: sum of 2 quarters · filed 2021-03-11 | ||
| 2019-12-31 | 1.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 1.71M shares 10-K · filed 2021-03-11 | ||
| 2019-09-30 | 695.73K shares 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | 580.40K shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |